Hypoxia and HIF activation as a possible link between sepsis and thrombosis.
Colin E EvansPublished in: Thrombosis journal (2019)
Risk factors for thrombosis include hypoxia and sepsis, but the mechanisms that control sepsis-induced thrombus formation are incompletely understood. A recent article published in Thrombosis Journal: (i) reviews the role of endothelial cells in the pathogenesis of sepsis-associated microthrombosis; (ii) describes a novel 'two-path unifying theory' of hemostatic discorders; and (iii) refers to hypoxia as a consequence of microthrombus formation in sepsis patients. The current article adds to this review by describing how sepsis and thrombus formation could be linked through hypoxia and activation of hypoxia-inducible transcription factors (HIFs). In other words, hypoxia and HIF activation may be a cause as well as a consequence of thrombosis in sepsis patients. While microthrombosis reduces microvascular blood flow causing local hypoxia and tissue ischemia, sepsis-induced increases in HIF1 activation could conversely increase the expression of coagulant factors and integrins that promote thrombus formation, and stimulate the formation of pro-thrombotic neutrophil extracellular traps. A better understanding of the role of cell-specific HIFs in thrombus formation could lead to the development of novel prophylactic therapies for individuals at risk of thrombosis.
Keyphrases
- endothelial cells
- septic shock
- acute kidney injury
- high glucose
- intensive care unit
- pulmonary embolism
- end stage renal disease
- blood flow
- ejection fraction
- chronic kidney disease
- transcription factor
- poor prognosis
- prognostic factors
- single cell
- systematic review
- vascular endothelial growth factor
- bone marrow
- patient reported outcomes
- cell therapy
- dna binding